The first proof that fisetin had antiangiogenic and anticancer properties in mice carrying LLC was presented by this study.61Another study found that fisetin inhibits A549 lung cancer cells' adhesion, migration, and invasion via downregulating uPA, ERK1/2, and MMP-2. Here, MMP2 is linked to lung carcinoma.